Carcinogenesis, Vol. 20, No. 7, 1379-1382,
July 1999
© 1999 Oxford University Press
Short Communications |
The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains
Institut für Toxikologie, Wilhelmstraße 56, 72074 Tübingen and
1 Institut für Genetik, Bonn, Germany
This paper is dedicated to Prof. H.Remmer on the occasion of his 80th birthday
Connexin32 (Cx32) is the major gap junctional protein in mouse liver. We have shown recently that the formation of liver tumours in Cx32-deficient mice is strongly increased in comparison with control wild-type mice, demonstrating that the deficiency in gap junctional communication has an enhancing effect on hepatocarcinogenesis. We have now compared the effect of Cx32 deficiency on liver carcinogenesis in two strains of mice with differing susceptibility to hepatocarcinogenesis. Heterozygous Cx32+/– females were crossed with male Cx32 wild-type C57BL/6J (low susceptibility) or C3H/He (high susceptibility) mice. Since the Cx32 gene is located on the X-chromosome, the resulting F1 males segregated to the genotypes Cx32Y/+ and Cx32Y/–. Genotyping was performed by PCR-analysis using tail-tip DNA. Weanling male mice were i.p. injected with a single dose of N-nitrosodiethylamine and were killed 16, 21 or 26 weeks later. The number, volume fraction and size distribution of precancerous liver lesions characterized by a deficiency in the marker enzyme glucose-6-phosphatase were quantitated. The results demonstrate that Cx32 deficiency only slightly affects the number of enzyme-altered lesions, but strongly enhances their growth, both in the resistant and the susceptible mouse strain, suggesting that decreased intercellular communication results in tumour promoting activity irrespective of the genetic background of the mouse strain used. Since Cx32-deficient C3H/He hybrids were ~5–10 times more sensitive than C3H/He hybrids with an intact Cx32 gene, this mouse strain may prove very useful for toxicological screening purposes.
Abbreviations: Cx32, connexin32; G-6-Pase, glucose-6-phosphatase; DEN, N-nitrosodiethylamine.
2 To whom correspondence should be addressed Email: michael.schwarz{at}uni-tuebingen.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Marx-Stoelting, J. Mahr, T. Knorpp, S. Schreiber, M. F. Templin, T. Ott, A. Buchmann, and M. Schwarz Tumor Promotion in Liver of Mice with a Conditional Cx26 Knockout Toxicol. Sci., June 1, 2008; 103(2): 260 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Marongiu, S. Doratiotto, S. Montisci, P. Pani, and E. Laconi Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin? Am. J. Pathol., April 1, 2008; 172(4): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hokaiwado, M. Asamoto, K. Ogawa, and T. Shirai Transgenic Disruption of Gap Junctional Intercellular Communication Enhances Early but Not Late Stage Hepatocarcinogenesis in the Rat Toxicol Pathol, October 1, 2005; 33(6): 695 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. King and P. D. Lampe The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor Cancer Res., October 15, 2004; 64(20): 7191 - 7196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Aguilar, J. M. Corominas, N. Malats, J. A. Pereira, M. Dufresne, F. X. Real, and P. Navarro Tissue Plasminogen Activator in Murine Exocrine Pancreas Cancer: Selective Expression in Ductal Tumors and Contribution to Cancer Progression Am. J. Pathol., October 1, 2004; 165(4): 1129 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. King and P. D. Lampe Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation Carcinogenesis, May 1, 2004; 25(5): 669 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Z. Dagli, H. Yamasaki, V. Krutovskikh, and Y. Omori Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver Carcinogenesis, April 1, 2004; 25(4): 483 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. SAEZ, V. M. BERTHOUD, M. C. BRANES, A. D. MARTINEZ, and E. C. BEYER Plasma Membrane Channels Formed by Connexins: Their Regulation and Functions Physiol Rev, October 1, 2003; 83(4): 1359 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Moennikes, S. Stahl, P. Bannasch, A. Buchmann, and M. Schwarz WY-14,643-mediated promotion of hepatocarcinogenesis in connexin32-wild-type and connexin32-null mice Carcinogenesis, September 1, 2003; 24(9): 1561 - 1565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Leithe, V. Cruciani, T. Sanner, S.-O. Mikalsen, and E. Rivedal Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C Carcinogenesis, July 1, 2003; 24(7): 1239 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Solan, M. D. Fry, E. M. TenBroek, and P. D. Lampe Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation J. Cell Sci., June 1, 2003; 116(11): 2203 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kobsar, M. Berghoff, M. Samsam, C. Wessig, M. Maurer, K. V. Toyka, and R. Martini Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1 Brain, April 1, 2003; 126(4): 804 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schwarz, I. Wanke, U. Wulbrand, O. Moennikes, and A. Buchmann Role of Connexin32 and {beta}-Catenin in Tumor Promotion in Mouse Liver Toxicol Pathol, January 1, 2003; 31(1): 99 - 102. [Abstract] [PDF]
|
|
|
|
|
|
M. Evert, T. Ott, A. Temme, K. Willecke, and F. Dombrowski Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice Carcinogenesis, May 1, 2002; 23(5): 697 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yano, F.-J. Hernandez-Blazquez, Y. Omori, and H. Yamasaki Reduction of malignant phenotype of HEPG2 cell is associated with the expression of connexin 26 but not connexin 32 Carcinogenesis, October 1, 2001; 22(10): 1593 - 1600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Jeong, S. S. M. Habeebu, and C. D. Klaassen Cadmium Decreases Gap Junctional Intercellular Communication in Mouse Liver Toxicol. Sci., September 1, 2000; 57(1): 156 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Moennikes, A. Buchmann, A. Romualdi, T. Ott, J. Werringloer, K. Willecke, and M. Schwarz Lack of Phenobarbital-mediated Promotion of Hepatocarcinogenesis in Connexin32-Null Mice Cancer Res., September 1, 2000; 60(18): 5087 - 5091. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. D. Lampe, E. M. TenBroek, J. M. Burt, W. E. Kurata, R. G. Johnson, and A. F. Lau Phosphorylation of Connexin43 on Serine368 by Protein Kinase C Regulates Gap Junctional Communication J. Cell Biol., June 26, 2000; 149(7): 1503 - 1512. [Abstract] [Full Text] [PDF]
|
|